Home Medicine Strategies of bacteria screening in cellular blood components
Article
Licensed
Unlicensed Requires Authentication

Strategies of bacteria screening in cellular blood components

  • Thomas Montag
Published/Copyright: July 1, 2008

Abstract

Since the impressive reduction of transfusion-transmitted virus infections, bacterial infections by blood transfusion represent the most important infection risk. Platelet concentrates are the current focus of attention, as they are stored under temperature conditions which allow growth of contaminating bacteria up to 1010 and more microbes per platelet bag. This paper does not consider the pathogen reduction methods but will assess suitable screening methods. Beside conventional microbiological approaches or surrogate markers, several efficient methods able to detect bacterial contamination in platelets are available on the market. They need to be divided into two different methodological principles: the cultivation methods and rapid methods. Cultivation or incubation methods require some time for signal production as they depend on growth of microbes. Thus, they have to be combined with early sampling, i.e., the sample to be examined has to be drawn from the blood component 1 day after donation. Their advantage is the relatively uncomplicated implementation into the logistics of blood banks. Because of the initially very low count of bacteria after donation, a certain small sampling error in application of that strategy remains. Rapid methods are able to produce the diagnosis within a short time. Therefore, they allow postponing of sample drawing, ideally up to the time immediately before transfusion. However, this procedure causes logistic complications. On the other hand, late sampling combined with a rapid method will prevent the transfusion of highly contaminated platelet concentrates leading to acute septic shock up to the death of the patient. Considering the sum of different aspects including the supply of patients, the potential improvement of microbial safety of platelet concentrates is comparable in both strategies.

Clin Chem Lab Med 2008;46:926–32.


Corresponding author: Thomas Montag-Lessing, MD, Paul-Ehrlich-Institute, Paul-Ehrlich-Straße 51–59, 63225 Langen, Germany

Published Online: 2008-07-01
Published in Print: 2008-07-01

©2008 by Walter de Gruyter Berlin New York

Articles in the same Issue

  1. Editorial
  2. CCLM: Evolving to meet the needs of today's laboratory professionals and scientists
  3. Bacterial detection and blood product contamination
  4. Editorial: Rapid diagnostic tests to detect pathogenic microorganisms
  5. Reviews
  6. Rapid methods for diagnosis of bloodstream infections
  7. Validation criteria for nucleic acid amplification techniques for bacterial infections
  8. Incidence of bacterial transmission and transfusion reactions by blood components
  9. Strategies of bacteria screening in cellular blood components
  10. Methods for the detection of bacterial contamination in blood products
  11. Bacteria detection by flow cytometry
  12. Rapid screening by real-time 16S rDNA PCR for bacterial contamination of blood products
  13. Microbial safety of cell based medicinal products – what can we learn from cellular blood components?
  14. Genetics and Molecular Diagnostics
  15. Screening for genetic heterogeneity in the interferon sensitivity determining region of the hepatitis C virus genome by polymerase chain reaction with melting curve analysis
  16. Thiopurine S-methyltransferase (TPMT) pharmacogenetics: three new mutations and haplotype analysis in the Estonian population
  17. Genetic testing for adult-type hypolactasia in Italian families
  18. Improved real-time detection of the H63D and S65C mutations associated with hereditary hemochromatosis using a SimpleProbe assay format
  19. Easy detection of 5,10-methylenetetrahydrofolate reductase 1298A/C genotype by mutagenically separated PCR assay
  20. General Clinical Chemistry and Laboratory Medicine
  21. Mediterranean diet and plasma concentration of inflammatory markers in old and very old subjects in the ZINCAGE population study
  22. Plasma interleukin-1β, -6, -8 and tumor necrosis factor-α as highly informative markers of pelvic inflammatory disease
  23. The effect of hypothyroidism, hyperthyroidism, and their treatment on parameters of oxidative stress and antioxidant status
  24. Breath isoprene – aspects of normal physiology related to age, gender and cholesterol profile as determined in a proton transfer reaction mass spectrometry study
  25. Prohormone brain natriuretic peptide (proBNP), BNP and N-terminal-proBNP circulating levels in chronic hemodialysis patients. Correlation with ventricular function, fluid removal and effect of hemodiafiltration
  26. A comparison of two different assays for determining S-100B in serum and urine
  27. Diagnostic, clinical and laboratory turnaround times in troponin T testing
  28. Validation and Outcome Studies
  29. An international comparability study to determine the sources of uncertainty associated with a non-competitive sandwich fluorescent ELISA
  30. A new general regression-based approach for method comparison studies
  31. Letters to the Editor
  32. Procalcitonin values in preeclamptic women are related to severity of disease
  33. Cross-reactivity between λ antiserum and fibrinogen: a double trap in interpretation of serum protein electrophoresis
  34. Erroneous result of white blood cell differential count in a patient with mixed hyperlipidemia
  35. Lack of association of GH T1663A variation and IGFBP3–202A/C polymorphism with risk of ischemic stroke in Chinese
  36. Erratum
  37. Quality planning and analytical quality requirements derived from biology
Downloaded on 11.2.2026 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2008.176/html
Scroll to top button